Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in New Jersey
| Provider | Medicare | Services |
|---|---|---|
| Laboratory Corporation Of America... | $21.78 | 5.9K |
| Quest Diagnostics Incorporated | $21.79 | 4.9K |
| Bioreference Health, Llc | $21.75 | 2.9K |
| Accu Reference Medical Lab, Llc | $21.78 | 2.5K |
| Centers Lab Nj Llc | $21.76 | 829 |
| Lincoln Diagnostics Llc | $21.79 | 238 |
| Novalab Corp | $21.79 | 195 |
| Medlife Diagnostic Laboratories | $21.79 | 170 |
| Siddique, Mahmood D.O. | $21.79 | 145 |
| Synergy Medical Laboratories Inc | $21.79 | 128 |
| Xeron Clinical Laboratories Inc. | $21.79 | 115 |
| Garbowit, David M.D. | $21.79 | 101 |
| Bazerbashi, Ammar MD | $21.79 | 98 |
| Rnj Services, Inc | $21.79 | 97 |
| Dower, Samuel MD | $21.79 | 78 |
| Rdx Bioscience, Inc | $21.79 | 75 |
| Chemisys Laboratories, Llc | $21.79 | 61 |
New Jersey Pricing in Context
In New Jersey, CPT code 82627 (Dehydroepiandrosterone (dhea-S) Hormone Level) carries an average Medicare payment of $21.78 — 0% above the national benchmark of $21.75. 77 providers across the state submitted claims for this procedure in 2023, performing 18.9K total services. Individual payments in NJ ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in New Jersey is $161.92, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because New Jersey sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Hormone Test procedures, the estimated commercial insurance price in New Jersey lands near $55.53, with self-pay cash prices typically around $60.86. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Dehydroepiandrosterone (dhea-S) Hormone Level cost in New Jersey?
The average Medicare payment for Dehydroepiandrosterone (dhea-S) Hormone Level in New Jersey is $21.78, which is 0% above the national average of $21.75. Providers in NJ typically bill $161.92 for this procedure.
What does Dehydroepiandrosterone (dhea-S) Hormone Level cost with insurance in New Jersey?
With commercial insurance in New Jersey, Dehydroepiandrosterone (dhea-S) Hormone Level costs an estimated $55.53. Without insurance, the estimated cash price is $60.86. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Dehydroepiandrosterone (dhea-S) Hormone Level in New Jersey?
77 providers in New Jersey billed Medicare for Dehydroepiandrosterone (dhea-S) Hormone Level in 2023, performing 18.9K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Dehydroepiandrosterone (dhea-S) Hormone Level cheaper in New Jersey than the national average?
No — Dehydroepiandrosterone (dhea-S) Hormone Level costs 0% above the national average in New Jersey. The state average Medicare payment is $21.78 compared to $21.75 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.